Targovax ASA: Fourth Quarter 2019 Results
- Wednesday, March 11, 2020, 6:57
- Finance
- Add a comment
OSLO, Norway, March 11, 2020 /PRNewswire/ — Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its fourth quarter 2019 results. A meeting for investors, analysts and press will take place in…
About the Author
adminasapcorp has written 41794 stories on this site.